Revenue
17.4 million USD
2012 Q3 · USD
Exact inputs and evidence
- Revenue: 17384697 USD Source
30 filing records in this dataset, filed from 2008-08-14 to 2012-11-19. Reported financial figures are available; chart coverage varies by period.
17.4 million USD
2012 Q3 · USD
6.04%
2012 Q3 · %
1.53 million USD
2012 Q3 · USD
1.52 million USD
2012 Q3 · USD
6397820 USD
59664480 shares
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2012-11-19.
Financial data available through: 2011-03-31.
Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 25.72 million
–
Current period
USD 29 million
–
28999198 − 25723902 = 3275296 USD
25723902 USD · 2009-04-01 – 2010-03-31
Inspect prior input Prior source28999198 USD · 2010-04-01 – 2011-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 2.76 million
–
Current period
USD 2.33 million
–
2333679 − 2762459 = -428780 USD
2762459 USD · 2009-04-01 – 2010-03-31
Inspect prior input Prior source2333679 USD · 2010-04-01 – 2011-03-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Operating cash flow, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2008 2007-04-01 – 2008-03-31 | 0 | Unavailable | Unavailable | Unavailable | -16998 | Unavailable | Source
|
| 2009 2008-04-01 – 2009-03-31 | 0 | Unavailable | Unavailable | Unavailable | -35083 | Unavailable | Source
|
| 2010 2009-04-01 – 2010-03-31 | 25723902 | 22004263 Derived | 3719639 | 957180 Derived | 2762459 | Unavailable | Source
|
| 2011 2010-04-01 – 2011-03-31 | 28999198 | 25776672 Derived | 3222526 | 888847 Derived | 2333679 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2008 | Revenue | 0 |
|
| 2009 | Revenue | 0 |
|
| 2010 | Revenue | 25723902 |
|
| 2011 | Revenue | 28999198 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2008 | Year over year | No prior comparable period |
|
| 2009 | Year over year | No prior comparable period |
|
| 2010 | Year over year | No prior comparable period |
|
| 2011 | Year over year | 12.7% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2008-03-31 | Operating margin | Not reported |
|
| 2009-03-31 | Operating margin | Not reported |
|
| 2010 | Operating margin | 14.5% |
|
| 2011 | Operating margin | 11.1% |
|
| 2008 | Net margin | Not reported |
|
| 2009 | Net margin | Not reported |
|
| 2010 | Net margin | 10.7% |
|
| 2011 | Net margin | 8% |
|
| 2008 | Free cash flow margin | Not reported |
|
| 2009 | Free cash flow margin | Not reported |
|
| 2010 | Free cash flow margin | Not reported |
|
| 2011 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2008 | Operating cash flow | -11498 |
|
| 2009 | Operating cash flow | -32494 |
|
| 2010 | Operating cash flow | -10189 |
|
| 2011 | Operating cash flow | Not reported | No source recorded |
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2008 | Free cash flow | Unavailable |
|
| 2009 | Free cash flow | Unavailable |
|
| 2010 | Free cash flow | Unavailable |
|
| 2011 | Free cash flow | Unavailable | No source recorded |
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2008 | Liabilities / assets | 17.2% |
|
| 2009 | Liabilities / assets | 0.1% |
|
| 2010 | Liabilities / assets | 211.6% |
|
| 2011 | Liabilities / assets | 148.1% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2008 | Current assets / current liabilities | 5.82× |
|
| 2009 | Current assets / current liabilities | 0.03× |
|
| 2010 | Current assets / current liabilities | 0.47× |
|
| 2011 | Current assets / current liabilities | 0.71× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2008 2007-04-01 – 2008-03-31 | −USD 16,998 Exact valueExact value: -16998 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 11,498 Exact valueExact value: -11498 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2009 2008-04-01 – 2009-03-31 | −USD 35,083 Exact valueExact value: -35083 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 32,494 Exact valueExact value: -32494 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2010 2009-04-01 – 2010-03-31 | USD 2.76 million Exact valueExact value: 2762459 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 10,189 Exact valueExact value: -10189 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2011 2010-04-01 – 2011-03-31 | USD 2.33 million Exact valueExact value: 2333679 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
30 filings · 579 latest values · 579 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001432254, 1432254, FCPG, edgar:1432254, fcpg
Also known as E DISPATCH INC, FIRST CHINA PHARMACEUTICAL GROUP, INC.